Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.76%
#4 aPriori aPriori +108.27%
#5 Bedrock Bedrock +74.39%
#6 Cysic Cysic +49.09%
#7 Prom Prom +38.71%
#8 Playnance Playnance +35.10%
#9 COTI COTI +26.15%
#10 Nillion Nillion +24.13%
Coin of the day
Wrapped One Wrapped One
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Clasificación en acciones #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Precio por acción
$0.85
Última sincronización: 2025-01-21
Capitalización bursátil
$411.40
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Fresh2 Group Limited (FRES)

Categoría

Healthcare
Ingresos de Fresh2 Group Limited (FRES)
Ingresos en Jun 2023 TTM: $1.64M
Según los últimos informes financieros de Fresh2 Group Limited, los ingresos actuales de la empresa (TTM) son $1.64M. En 2021, la empresa obtuvo unos ingresos de $2.79M una disminución en comparación con los ingresos del año 2020, que fueron de $2.97M. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Fresh2 Group Limited desde 2017 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
2026 (TTM) $1.64M -5.98%
2022 $1.75M -37.49%
2021 $2.79M -5.89%
2020 $2.97M 91.09%
2019 $1.55M 0.32%
2018 $1.55M 81.73%
2017 $851.95K 0.00%
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 768,932.17%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 366,697.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 615,816.94%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR